|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.445 HKD | -1.11% |
|
+14.10% | -28.23% |
| 12/04 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
| 08/04 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
On April 12, 2024, Clover Biopharmaceuticals, Ltd closed the transaction. The transaction included participation from 10 investors, which includes a single non-accredited investor.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.23% | 73.88M | |
| +7.52% | 111B | |
| +11.38% | 106B | |
| -12.64% | 22.24B | |
| +0.44% | 21.25B | |
| -4.18% | 18.97B | |
| -37.85% | 18.52B | |
| -8.58% | 16.81B | |
| +37.41% | 12.54B | |
| -23.95% | 8.09B |
CLOVER BIOPHARMACEUTICALS, LTD. 